IRIS
BENNETT, DAVID
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.248
NA - Nord America 8.076
AS - Asia 3.721
SA - Sud America 610
AF - Africa 185
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.861
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.913
IT - Italia 2.217
RU - Federazione Russa 1.789
GB - Regno Unito 1.327
SG - Singapore 1.119
CN - Cina 1.030
IE - Irlanda 906
BR - Brasile 510
VN - Vietnam 495
DE - Germania 446
FR - Francia 364
SE - Svezia 364
HK - Hong Kong 341
UA - Ucraina 234
FI - Finlandia 222
IN - India 150
BD - Bangladesh 117
KR - Corea 115
CA - Canada 99
ZA - Sudafrica 96
ES - Italia 76
NL - Olanda 60
TR - Turchia 59
PL - Polonia 53
CZ - Repubblica Ceca 46
JP - Giappone 46
IQ - Iraq 42
AR - Argentina 38
MX - Messico 37
AT - Austria 25
CI - Costa d'Avorio 24
BE - Belgio 23
ID - Indonesia 22
UZ - Uzbekistan 22
MA - Marocco 17
IR - Iran 16
NG - Nigeria 16
AU - Australia 15
EC - Ecuador 15
VE - Venezuela 15
AZ - Azerbaigian 14
PH - Filippine 14
AE - Emirati Arabi Uniti 13
CH - Svizzera 13
JO - Giordania 12
PK - Pakistan 12
SA - Arabia Saudita 12
LT - Lituania 11
IL - Israele 10
KE - Kenya 10
MY - Malesia 10
EG - Egitto 9
KZ - Kazakistan 9
GR - Grecia 8
PE - Perù 8
HU - Ungheria 7
JM - Giamaica 7
MK - Macedonia 7
RO - Romania 7
PT - Portogallo 6
UY - Uruguay 6
BO - Bolivia 5
CO - Colombia 5
CR - Costa Rica 5
CY - Cipro 5
DK - Danimarca 5
KG - Kirghizistan 5
PY - Paraguay 5
AL - Albania 4
BG - Bulgaria 4
BY - Bielorussia 4
DZ - Algeria 4
NO - Norvegia 4
CL - Cile 3
EU - Europa 3
GE - Georgia 3
HR - Croazia 3
LK - Sri Lanka 3
PA - Panama 3
AM - Armenia 2
ET - Etiopia 2
GD - Grenada 2
HN - Honduras 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AO - Angola 1
Totale 20.838
Salva come PNG Salva come JPEG
Città #
Dallas 1.410
Southend 1.108
Dublin 890
Singapore 708
Ashburn 593
Fairfield 578
Moscow 526
San Jose 457
Chandler 443
Santa Clara 404
Hong Kong 314
Beijing 285
Siena 284
Woodbridge 254
Seattle 215
Wilmington 208
Ann Arbor 200
Milan 196
Los Angeles 186
Cambridge 184
Houston 182
Jacksonville 180
Hefei 176
Munich 165
New York 159
Ho Chi Minh City 147
Florence 135
Helsinki 123
Princeton 120
Seoul 113
Council Bluffs 111
Lauterbourg 105
Hanoi 95
Johannesburg 87
The Dalles 86
Rome 68
Buffalo 60
Boardman 58
Chicago 54
Dearborn 54
Nanjing 53
Dong Ket 50
London 49
Turku 47
Orem 45
Shanghai 44
Warsaw 44
Frankfurt am Main 43
Tokyo 43
Fremont 42
Málaga 42
São Paulo 40
San Mateo 37
Catania 36
Nuremberg 36
Chennai 35
Montreal 29
Bengaluru 28
Toronto 27
Da Nang 26
Menlo Park 26
San Diego 26
Abidjan 24
Atlanta 24
Izmir 24
Brno 23
Düsseldorf 23
Denver 22
Brussels 21
Columbus 21
Manchester 21
Lappeenranta 20
Mumbai 20
Nanchang 20
Washington 20
Guangzhou 19
Olomouc 19
Phoenix 19
Poplar 19
Redondo Beach 19
San Francisco 19
Tashkent 19
Baghdad 18
Brooklyn 18
Changsha 18
Lastra a Signa 18
Shenyang 18
Gavirate 17
Paris 17
Turin 17
Abuja 16
Naples 16
Padova 16
Haiphong 15
Messina 15
Amsterdam 14
Bologna 14
Boston 14
Hebei 14
Brescia 13
Totale 13.273
Salva come PNG Salva come JPEG
Nome #
La chitotriosidasi: un sensibile biomarker di sarcoidosi 1.043
A first update on mapping the human genetic architecture of COVID-19 582
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 418
Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis 389
An explainable model of host genetic interactions linked to COVID-19 severity 371
Antirheumatic agents in covid-19: is IL-6 the right target? 360
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 356
Peripheral biomarkers' panel for severe COVID-19 patients 319
Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers 306
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 303
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 291
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 285
Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis 282
Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns 275
Exhaled nitric oxide in interstitial lung diseases 274
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 266
Idiopathic pulmonary fibrosis a rare disease with severe bone fragility 264
Airway-Centered Pleuroparenchymal Fibroelastosis Associated with Non-Necrotizing Granulomas: A Rare New Entity 264
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 259
Prognostic bioindicators in severe COVID-19 patients 256
Diagnosis of idiopathic pulmonary fibrosis by virtual means using “IPFdatabase”- a new software 255
Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience 250
Serial KL-6 measurements in COVID-19 patients 249
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 247
Posttransplant solid organ malignancies in lung transplant recipients: A single-center experience and review of the literature 245
Serum chitotriosidase levels in patients with allergic and non-allergic asthma 242
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 242
Diffuse panbronchiolitis in a patient with common variable immunodeficiency: a casual association or a pathogenetic correlation? 238
Serum amyloid A in patients with idiopathic pulmonary fibrosis 237
Bronchial stenosis following lung transplant: An innovative approach with a modified endobronchial emphysema valve 236
Rituximab Therapy in Interstitial Lung Disease associated with Rheumatoid Arthritis 236
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 228
Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent 225
Pirfenidone therapy for familial pulmonary fibrosis: a real-life study. 225
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 223
Strategies for Maximising Lung Utilisation in Donors After Brain and Cardiac Death: A Narrative Review 221
SARS-CoV-2 in pleural fluid in a kidney transplant patient 219
Pirfenidone in chronic lung allograft dysfunction: a single cohort study 217
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 214
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 212
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 212
Chitotriosidase: a sensitive biomarker of sarcoidosis 206
WES profiling of COVID-19 206
Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence 203
Extracorporeal Photopheresis in Lung Transplantation 202
Whole-genome sequencing reveals host factors underlying critical COVID-19 201
Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis 201
Oxidative stress in the pathogenesis of diffuse lung diseases: a review 198
Proteomic investigation of pulmonary sarcoidosis 198
Impact of SARS-CoV-2 outbreak on heart and lung transplant: a patient-perspective survey 198
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 198
Alteration of Immune-checkpoint after specific stimulation with CMV antigens in pre-LTx patients 196
Biomarkers in sarcoidosis: The contribution of system biology 194
Human Chitotriosidase: a sensitive biomarker of sarcoidosis 193
BIOMARKERS WITH CLINICAL SIGNIFICANCE IN PATIENTS WITH INTERSTITIAL LUNG DISEASES 192
Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution 192
IPF mortality in waiting list for lung transplantation 190
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 177
Helicobacter pylori antibody positivity in idiopathic pulmonary fibrosis 177
Mortalità in lista per trapianto di polmone in pazienti affetti da fibrosi polmonare idiopatica 175
Timing of Osteoporotic Vertebral Fractures in Lung and Heart Transplantation: A Longitudinal Study 170
Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant 166
Familial pulmonary fibrosis: Clinical-functional and radiological features 165
null 165
Rischio infettivo nel trapianto di polmone per fibrosi polmonare: analisi retrospettiva 165
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study 164
New concepts in the pathogenesis of sarcoidosis 162
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 158
Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosis 157
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 156
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction 156
Outcome of ECMO bridge to lung transplantation: a single cohort study 156
Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective 155
IPFdatabase - A new tool for a correct application of idiopathic pulmonaty fibrosis guidelines 153
The Role of Galectins in Chronic Lung Allograft Dysfunction 151
Incidenza e fattori di rischio per colonizzazione ed infezione respiratoria batterica a 30 giorni in pazienti trapiantati di polmone 151
Cavernous sinus syndrome due to neurosarcoidosis in adolescence: a diagnosis not to be missed 150
Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study 146
null 145
Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseases 144
Valutazione dell'ossido nitrico nell'esalato delle polmoniti interstiziali idiopatiche 139
Exhaled nitric oxide and carbon monoxide in lung transplanted patients 137
Pulse oximetry oxyhemoglobin saturation in patients with idiopathic pulmonary fibrosis 131
Relapses of idiopathic inflammatory myopathies after vaccination against COVID19: a real-life Italian study 128
Lung transplantation in patients with previous or unknown oncological disease: evaluation of short- and long-term outcomes 124
Donor-Recipient Mismatch in Lung Transplantation: The Role of Graft Sizing in Clinical Outcomes 121
null 121
Assessing Short- and Medium-Term Outcomes of Lung Transplantation in Elderly Recipients: A Comparative Age-Based Analysis 120
Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP 116
NK and T cell in patients with end-stage lung disorders waiting for lung transplantation in response to CMV infection 108
NK and T cells responses to CMV in patients awaiting for lung transplantation 107
null 106
Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity 105
Nintedanib in Idiopathic Pulmonary Fibrosis: a single-centre real-life experience 105
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review 105
Objective Effects and Patient Preferences for Ambulatory Oxygen in Fibrotic Interstitial Lung Disease With Isolated Exertional Hypoxaemia: A Placebo‐Controlled 6‐Minute Walk Test Study 104
Calgranulin B/S100A9 and KL-6 in bronchoalveolar lavage of patients with IPF and NSIP 99
Erratum: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis (Respiratory Research (2020) 21 (6) DOI: 10.1186/s12931-019-1263-z) 84
A novel web-based tool for lung transplant patients undergoing extracorporeal photopheresis 77
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica. 50
Totale 21.055
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.519
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021123 0 0 0 0 0 0 0 0 0 0 0 123
2021/20221.230 93 153 86 97 71 47 57 72 50 118 146 240
2022/20231.799 145 187 195 225 152 266 157 151 154 74 57 36
2023/20241.752 76 49 179 89 80 408 532 67 15 48 51 158
2024/20253.150 108 161 417 152 371 198 169 164 199 139 355 717
2025/20268.252 553 993 1.186 1.053 1.687 304 1.007 243 269 507 275 175
Totale 21.221